LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.
Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.
Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.
Lung Cancer Europe (LuCE) held a webinar on the lung cancer molecular testing. The webinar was given by Rolf A. Stahel, M.D., President ETOP Foundation, President IBCSG Foundation and Editor of Cancer Treatment Reviews The webinar was held and recorded on 8th December 2020.
Lung Cancer Europe (LuCE) held a webinar on the role of radiotherapy in lung cancer management. The webinar was given by Virginia Ruiz Martin MD, Radiation Oncologist Consultant, Department of Radiation Oncology at the University Hospital of Burgos, Spain. The webinar was held and recorded on 17th November 2020
18 & 19 November 2020, Virtual Edition Working Together Against Cancer: Breaking Down Barriers & Saving Lives Every year, the European Cancer Organisation brings together leading oncology specialists, patient advocates, politicians and policy-makers to discuss the main issues impacting cancer policy, for the benefit of citizens, cancer patients and healthcare professionals across Europe. The European Cancer Summit 2020 will include […]
Lung Cancer Europe (LuCE) held a webinar on ESMO 2020 lung cancer highlights. The webinar was given by Professor Sanjay Popat FRCP PhD, Consultan Medical Oncologist, Royal Marsden Hospital and Professor of Thoracic Oncology, The Institute of Cancer Research in London, UK. The webinar was held and recorded on 15th October 2020
